Navigation Links
Verizon Wireless' Network Supports VectraCor's Ambulatory Cardiac Monitor

LAS VEGAS, BASKING RIDGE, N.J., and TOTOWA, N.J., Jan. 10, 2012 /PRNewswire/ -- From the 2012 International Consumer Electronics Show (CES), Verizon Wireless and VectraCor, Inc. today said the Vectraplex Holter System is being shown at the Verizon booth (Las Vegas Convention Center, South Hall, Booth #30259). 

The Vectraplex Holter System is an ambulatory cardiac monitor that incorporates an electrocardiogram (ECG) amplifier and a cell module using Verizon Wireless service.  Currently under development, the Vectraplex Holter will use the "Cardiac Electrical Biomarker," VectraplexAMI, which received FDA approval in November 2011, on VectraCor's VectraplexECG System.  This technology will detect ECG changes indicative of an acute myocardial infarction (AMI, heart attack), non-invasively and in real time, and display a derived 15 lead ECG from the acquisition of 3 leads (5 electrodes).  For the first time, a patient can be anywhere on the Verizon Wireless network and the Vectraplex Holter System will automatically send an email over the network to the physician when the patient is having ECG changes indicative of an AMI or other events, allowing the physician to review the derived 15 lead ECG.  The device will also send data on patient-initiated events.

Cardiovascular disease is the No. 1 killer in the world, and the need to improve the detection and monitoring of a heart attack is crucial.  The current emergency room practice of chest pain evaluation is to connect the patient to a cardiac monitor (3-5 electrodes), then connect an additional 12 lead ECG machine (additional 10 electrodes), and then draw blood to measure serum biomarkers, repeated approximately every three to six hours during an 18- to 24-hour-period.

The Vectraplex Holter System is an ambulatory cardiac monitor that patients can wear at home or in the hospital to detect ECG changes suggestive of an AMI within seconds and derive the 15 lead ECG (12 lead and vectorcardiogram XYZ leads, including VCG loops) from the acquisition of only 3 leads (5 electrodes).  VectraCor's disruptive technology is patented worldwide and will provide valuable clinical information to both patients and clinicians.

Brad S. Schreck, president and chief executive officer for VectraCor, said, "VectraCor is very pleased to work with Verizon Wireless, enabling our disruptive technology to help patients with cardiovascular disease, the No. 1 killer in the world.  We expect to submit the 510k to the FDA in the first quarter of 2012 for this new product."

Verizon established its Innovation Program to encourage collaboration and help advance the 4G LTE ecosystem.  The company's LTE Innovation Center in Waltham, Mass., and its Application Innovation Center in San Francisco were created to inspire, enable and develop non-traditional devices, services and applications that take advantage of Verizon Wireless' industry-leading wireless networks.  Through the Innovation Program, Verizon seeks to expand the possibilities of 4G LTE by working with diverse companies, from start-ups to established players, in industries representing a broad range of verticals.

For more information about Verizon at CES, visit or follow Verizon Wireless news on Twitter at @VZWnews.  Visit for more information about VectraCor.

About Verizon Wireless
Verizon Wireless operates the nation's largest 4G LTE network and largest, most reliable 3G network. The company serves 107.7 million total wireless connections, including 90.7 million retail customers.  Headquartered in Basking Ridge, N.J., with nearly 83,000 employees nationwide, Verizon Wireless is a joint venture of Verizon Communications (NYSE, NASDAQ: VZ) and Vodafone (LSE, NASDAQ: VOD).  For more information, visit To preview and request broadcast-quality video footage and high-resolution stills of Verizon Wireless operations, log on to the Verizon Wireless Multimedia Library at    

About VectraCor, Inc.
VectraCor is a medical device company in Totowa, NJ with disruptive patented technology in the cardiovascular market place.  Cardiovascular disease is the #1 disease and killer in the US and World.  VectraCor's technology has the potential to be the new standard of care in cardiac monitoring. For more information please visit VectraCor at or contact Brad S. Schreck at 973-768-0402 or email  

SOURCE Verizon Wireless
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Verizon Wireless and Medco Unveil First Mobile Medication App with Real-Time Patient-Specific Drug Safety and Savings Information
2. BL Healthcares Next Generation of Wireless Remote Healthcare Solutions, Now on Verizon Wireless 4G LTE Mobile Broadband Network
3. Verizon Expands Medical Data Exchange to Include Broader Range of Patient Health Data
4. Specialized Verizon Business Security Consulting Services Help Identify, Protect Personal Health Data
5. Verizon Business Adds Riverbed Application Acceleration Technology, New Consulting Services to Boost Performance of Key Business Applications
6. Verizon Wireless Offers Home Health Care Industry Custom Mobile Application To Be More Productive
7. Wireless Engineering Pioneer Joins NYU-Poly and NYU
8. Sotera Wireless Completes $12.2 Million Series D Financing, Signs Agreement with Cerner
9. Hello Health Inc. to Wirelessly Integrate the Hello Health® Patient Management Platform onto Qualcomm Lifes 2net Platform
10. BodyMedia Plans to Join Qualcomm Lifes Wireless Health 2net Ecosystem
11. CareFusion Launches Wireless Diagnostic and Monitoring Neurological Device
Post Your Comments:
(Date:6/23/2016)... Research and Markets has announced the addition of ... their offering. The current ... environment for MedImmune to enter. The US ageing population creates ... drive considerable growth for effective anti-influenza medications. The introduction of ... but development is still in its infancy. ...
(Date:6/23/2016)... Ill. and BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment ... Astellas Farma Brasil as the company,s second affiliate in Latin America . ... ... General Manager of Astellas Farma Colombia ... ...
(Date:6/23/2016)... 2016 Research and Markets has ... Global Analysis (United States, China, Japan, Brazil, United Kingdom, ... their offering. Surgical ... business planners, provides surgical procedure volume data in a ... an in-depth analysis of growth drivers and inhibitors, including ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... recently awarded their highest ... . , Millions of individuals in the United States and Canada wear eyeglasses. Once ... to both correct vision and make a fashion statement. Even celebrities use glasses as ...
(Date:6/26/2016)... ... ... On June 10-11, 2016, A Forever Recovery, a holistic treatment center for ... Table in Battle Creek, MI, where the rehabilitation facility is located. This annual celebration ... world’s leading providers of cereal and other breakfast foods. Its residents often refer to ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements owned ... developed to enhance the health of felines. The formula is all-natural and is made ... in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root ...
(Date:6/26/2016)... Orion, Clarkston, Michigan (PRWEB) , ... June 26, ... ... with respect to fertility once they have been diagnosed with endometriosis. These women ... intercourse but they also require a comprehensive approach that can help for preservation ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs ... College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. ... treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. ...
Breaking Medicine News(10 mins):